(Q34604998)

3 August 2017

Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

David Devos

1

0 references

Jean-Michel Sénard

0 references

author name string

French DUODOPA Study Group

series ordinal

2

1 reference

PubMed ID

19253412

3 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

3 August 2017

1 reference

3 August 2017

24

1 reference

3 August 2017

7

1 reference

3 August 2017

993-1000

1 reference

Apomorphine: an underutilized therapy for Parkinson's disease

3 August 2017

1 reference

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients

21 January 2018

1 reference

Duodenal levodopa infusion in Parkinson's disease--long-term experience

21 January 2018

1 reference

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets

21 January 2018

1 reference

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature

21 January 2018

1 reference

Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.

21 January 2018

1 reference

Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22450

1 reference

3 August 2017

1 reference

PubMed ID

19253412